These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 2615545

  • 1. [Prevalence of buprenorphine use by heroin addicts undergoing treatment].
    San L, Tremoleda J, Ollé JM, Porta Serra M, de la Torre R.
    Med Clin (Barc); 1989 Nov 25; 93(17):645-8. PubMed ID: 2615545
    [Abstract] [Full Text] [Related]

  • 2. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I, Pani PP, Pacini M, Perugi G.
    J Subst Abuse Treat; 2007 Jul 25; 33(1):91-8. PubMed ID: 17588494
    [Abstract] [Full Text] [Related]

  • 3. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I, Vidal-Trécan G, Nabet N, Boissonnas A.
    Encephale; 2002 Jul 25; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [Abstract] [Full Text] [Related]

  • 4. Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988 and 1990.
    San L, Torrens M, Castillo C, Porta M, de la Torre R.
    Addiction; 1993 Oct 25; 88(10):1341-9. PubMed ID: 8251871
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T, Vavrinková B.
    Neuro Endocrinol Lett; 2008 Feb 25; 29(1):80-6. PubMed ID: 18283247
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Buprenorphine as maintenance treatment in rehabilitation of heroin addicts].
    Bramness JG, Bachs LC, Waal H.
    Tidsskr Nor Laegeforen; 2002 Oct 20; 122(25):2452-4. PubMed ID: 12448114
    [Abstract] [Full Text] [Related]

  • 13. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S, Kemmler G, Ertl M, Riemer Y.
    Subst Use Misuse; 2006 Oct 20; 41(2):223-44. PubMed ID: 16393744
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function.
    Sacerdote P, Franchi S, Gerra G, Leccese V, Panerai AE, Somaini L.
    Brain Behav Immun; 2008 May 20; 22(4):606-13. PubMed ID: 18294814
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Magura S, Haddox JD.
    Drug Alcohol Depend; 2007 Sep 06; 90(1):64-71. PubMed ID: 17386981
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.